Baird, J., Battle, K., & Howes, R. (2018). Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: The problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms. BioMed Central.
Chicago Style (17th ed.) CitationBaird, J., K. Battle, and R. Howes. Primaquine Ineligibility in Anti-relapse Therapy of Plasmodium Vivax Malaria: The Problem of G6PD Deficiency and Cytochrome P-450 2D6 Polymorphisms. BioMed Central, 2018.
MLA引文Baird, J., et al. Primaquine Ineligibility in Anti-relapse Therapy of Plasmodium Vivax Malaria: The Problem of G6PD Deficiency and Cytochrome P-450 2D6 Polymorphisms. BioMed Central, 2018.
警告:這些引文格式不一定是100%准確.